RxDoctor Payments Data

Alie Jreisat, MD

Family Practice · Kingman, AZNPI 1578130555

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 37.8% of the total. Among family practice clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$654in general payments, 2019–2025

Across 19 payments — averaging $34.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$247
  • Medtronic$103
  • Amgen$72
  • Exact Sciences$56
  • Lilly USA, LLC$41
  • Novo Nordisk$41
  • plus $95 from 4 others

What the payments were for

  • Food & beverage$654100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654 in reported general payments places this provider in the 95th percentile of 267 family practice providers in Arizona.

See all family practice providers in Arizona

Medicare billing

Part B allowed, 2024
$64,676
Medicare patients
289
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide20$24,476
Gabapentin31$781
Metoprolol Succinate24$363
Levothyroxine Sodium49$353
Rosuvastatin Calcium13$341
Lisinopril56$331
Atorvastatin Calcium48$328
Tamsulosin Hcl20$286
Metformin Hcl30$204
Losartan Potassium16$204
Trazodone Hcl17$176
Montelukast Sodium14$143
Famotidine11$134
Omeprazole21$132
Glipizide12$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$41$24,47620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 267 family practice providers in Arizona.

Other family practice in Kingman

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →